The global computer vision in healthcare market size surpassed USD 1.92 billion in 2023 and is estimated to increase from USD 2.60 billion in 2024 to approximately USD 53.01 billion by 2034. It is projected to grow at a CAGR of 35.21% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Computer Vision in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Computer Vision in Healthcare Market, by Component, 2024-2034
8.1.1 Software
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. On-premise
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cloud-based
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Services
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. Computer Vision in Healthcare Market, by Application, 2024-2034
9.1.1. Medical Image & Diagnosis
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Surgical Assistance
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Patient’s Identification
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Remote Patient Monitoring
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Computer Vision in Healthcare Market, by End-user, 2024-2034
10.1.1. Hospital & Clinics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Diagnostics Centers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Academic Research Institutes
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Other End-Users
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Forecast, by End-user (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.2.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.3.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.6.3. Market Revenue and Forecast, by End-user (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
11.4.7.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.4.3. Market Revenue and Forecast, by End-user (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
11.5.5.3. Market Revenue and Forecast, by End-user (2021-2034)
12.1. AltexSoft
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. AiCure
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Encord
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. on
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. InData Labs
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Insoftex
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NVIDIA Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Robovision BV.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Shaip
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Softengi
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample